A Rare Combination Consisting of Primary Hyperaldosteronism and Glucagonoma

Abe, Hideki; Kubota, Keiichi; Noie, Tamaki; Kimura, Wataru; Makuuchi, Masatoshi
May 1999
American Journal of Gastroenterology;May1999, Vol. 94 Issue 5, p1397
Academic Journal
A 59-yr-old man with multiple pancreatic tumors is presented. Previously, he had undergone left adrenalectomy for primary hyperaldosteronism and left nephrectomy for renal cell carcinoma at the ages of 39 and 55 yr. respectively. This time, 3 yr after removal of renal cancer, two solid lesions in the pancreas associated with hyperglucagonemia were detected. Under a diagnosis of pancreatic metastasis from renal cell carcinoma or islet cell tumor of the pancreas, distal pancreatectomy with splenectomy and enucleation of the tumor in the pancreas head were performed. Microscopically, a glucagonoma, measuring 2.3 mm in diameter, was detected among five pancreatic metastases from renal cell carcinoma. Four years after surgery, the patient remains well, without signs of recurrence despite multiple pancreatic metastases. This is the first report of such a rare combination consisting of aldosterone-secreting adrenal adenoma and glucagonoma.


Related Articles

  • A rare case of an aldosterone secreting metastatic adrenocortical carcinoma and papillary thyroid carcinoma in a 31-year-old male. Wanta, Stephen M.; Basina, Marina; Chang, Steven D.; Chang, Daniel T.; Ford, James M.; Greco, Ralph; Kingham, Kerry; Merritt, Robert E.; Kunz, Pamela L. // Rare Tumors;2011, Vol. 3 Issue 4, p141 

    We report a rare synchronous presentation of adrenocortical carcinoma (ACC) and papillary thyroid carcinoma (PTC). A 31-year-old male first presented with a large left adrenal mass that was identified during the workup for refractory hypertension due to hyperaldosteronism. The mass was removed...

  • Adrenocortical Carcinoma With Concomitant Myelolipoma in a Patient With Hyperaldosteronism. Sun, Xichun; Ayala, Alberto; Castro, Claudia Y. // Archives of Pathology & Laboratory Medicine;Jun2005, Vol. 129 Issue 6, pe144 

    We present a case of aldosterone-secreting adrenocortical carcinoma with concomitant myelolipoma. To the best of our knowledge, this is the first such reported case. The patient was a 43-year-old man with severe hypertension. Clinical workup revealed an increased serum aldosterone level,...

  • Aldosterone-Producing Adrenocortical Carcinoma. Arteaga, Eugenio; Biglieri, Edward G.; Kater, Claudio; Lopez, Jose M.; Schambelan, Morris // Annals of Internal Medicine;Sep84, Vol. 101 Issue 3, p316 

    Presents information on a study that examined three patients with primary aldosteronism due to adrenocortical carcinoma. Research methods; Results and discussion.

  • Secondary Aldosteronism.  // Encyclopedic Reference of Molecular Pharmacology;2004, p843 

    An encyclopedia entry for "secondary aldosteronism," which refers to the condition in which the plasma aldosterone concentration is above the normal range due to various pathophysiological states, is presented.

  • Is Surgery Beneficial for MEN1 Patients with Small (≤2 cm), Nonfunctioning Pancreaticoduodenal Endocrine Tumor? An Analysis of 65 Patients from the GTE. Triponez, Frederic; Goudet, Pierre; Dosseh, David; Cougard, Patrick; Bauters, Catherine; Murat, Arnaud; Cadiot, Guillaume; Niccoli-Sire, Patricia; Calender, Alain; Proye, Charles A. G. // World Journal of Surgery;May2006, Vol. 30 Issue 5, p654 

    Background: The management of small, nonfunctioning pancreaticoduodenal endocrine tumors (NFPET) in multiple endocrine neoplasia type 1 (MEN1) patients is still controversial. We therefore investigated the effect of surgery on survival and tumor progression in MEN1 patients with NFPET ⩽2 cm...

  • Primary Aldosteronism. Weinberger, Myron H.; Grim, Clarence E.; Hollifield, John W.; Kem, David C.; Ganguly, Arunabha; Kramer, Norman J.; Yune, Heun Y.; Wellman, Henry; Donohue, John P. // Annals of Internal Medicine;Mar79, Vol. 90 Issue 3, p386 

    Presents information on a study which examined the diagnostic techniques used for the detection of primary aldosteronism. Methodology; Results; Discussion.

  • Primary acquired hypoaldosteronism. Kokko, Juha P. // Kidney International;Apr1985, Vol. 27 Issue 4, p690 

    Focuses on the study concerning the primary acquired hypoaldosteronism. Presentation of a case study involving a woman with the disorder; Periods of weakness experienced by the patient; Result of the urinalysis of the patient.

  • A patient with concurrent primary aldosteronism and Page kidney. Chin-Chi Kuo; Huan-Lun Hsu; Chao-Yuan Huang; Kao-Lang Liu; Vin-Cent Wu; Ching-Wei Tsai; Wei-Jie Wang // Endocrine (1355008X);Aug2010, Vol. 38 Issue 1, p6 

    The ratio of aldosterone-to-renin activity is currently recommended as a screening test for primary aldosteronism (PA). There are many factors interfering the interpretation of aldosterone-renin ratio (ARR) and could hamper in-time diagnosis of PA. Here, we first report a patient with underlying...

  • Long-Term Results of Adrenalectomy in Patients with Aldosterone-Producing Adenomas: Multivariate Analysis of Factors Affecting Unresolved Hypertension and Review of the Literature. Lumachi, Franco; Ermani, Mario; Basso, Stefano M. M.; Armanini, Decio; Iacobone, Maurizio; Favia, Gennaro // American Surgeon;Oct2005, Vol. 71 Issue 10, p864 

    The long-term surgical cure rate of patients with primary aldosteronism varies widely, and causes of persistent hypertension are not completely established. We reviewed retrospectively charts from 98 patients (range, 19-70 years old) with aldosterone-producing adenomas who underwent unilateral...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics